jrnl3555

Publication Venue For

  • Interactions between cocaine and the putative allosteric dopamine transporter ligand SRI-31142.  367:222-233. 2018
  • Diisopropylfluorophosphate Impairs the Transport of Membrane-Bound Organelles in Rat Cortical Axons..  356:645-655. 2016
  • Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.  353:529-538. 2015
  • Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome.  351:467-473. 2014
  • Therapeutic targeting of Src kinase in myofibroblast differentiation and pulmonary fibrosis.  351:87-95. 2014
  • Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat.  349:21-28. 2014
  • Correction to "The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys" (J Pharmacol Exp Ther (2011) 336, (682-692)).  342:596. 2012
  • Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-hexylpyridylporphyrin, MnTnHex-2-PyP: Rodent models of ischemic stroke and subarachnoid hemorrhage.  338:906-916. 2011
  • Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.  338:263-270. 2011
  • The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys.  336:682-692. 2011
  • The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal models.  336:751-766. 2011
  • Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis.  334:430-438. 2010
  • Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia.  333:528-532. 2010
  • Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.  335:124-132. 2010
  • Silibinin attenuates amyloid β25-35 peptide-induced memory impairments: Implication of inducible nitric-oxide synthase and tumor necrosis factor-α in mice.  331:319-326. 2009
  • Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: Effects of dopamine antagonists.  330:633-640. 2009
  • Studies of the biogenic amine transporters. 13. identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine release.  329:718-728. 2009
  • Identification of human CYP2C8 as a retinoid-related orphan nuclear receptor target gene.  329:192-201. 2009
  • Increased oxidant activity mediates vascular dysfunction in vibration injury.  328:223-230. 2009
  • Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release.  326:286-295. 2008
  • Determination of adenosine effects and adenosine receptors in murine corpus cavernosum.  322:678-685. 2007
  • Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure.  321:469-476. 2007
  • A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.  321:213-220. 2007
  • Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: Implications for treatment of fibrotic diseases.  321:35-44. 2007
  • Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats.  320:1216-1223. 2007
  • Metformin prevents endotoxin-induced liver injury after partial hepatectomy.  316:1053-1061. 2006
  • Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta.  315:1058-1064. 2005
  • Transforming growth factor-β-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent.  315:1005-1012. 2005
  • P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid.  311:1211-1217. 2004
  • Comparison of Pulmonary/Nasal CYP2F Expression Levels in Rodents and Rhesus Macaque.  309:127-136. 2004
  • Roles of Catalase and Hydrogen Peroxide in Green Tea Polyphenol-Induced Chemopreventive Effects.  308:317-323. 2004
  • Nucleotide-induced restoration of conjunctival chloride and fluid secretion in adenovirus type 5-infected pigmented rabbit eyes.  305:1206-1211. 2003
  • Phosphorylation of 4′-thio-β-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.  304:1314-1322. 2003
  • Differential effects of haloperidol and clozapine on [3H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain.  301:197-209. 2002
  • In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid μ-agonist/δ-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.  297:597-605. 2001
  • Modifications in the phosphoinositide signaling pathway by adrenal glucocorticoids in rat brain: Focus on phosphoinositide-specific phospholipase C and inositol 1,4,5-trisphosphate.  295:244-254. 2000
  • A mibefradil metabolite is a potent intracellular blocker of L-type Ca2+ currents in pancreatic β-cells.  292:939-943. 2000
  • Adrenal glucocorticoids modulate [3H]cyclic AMP binding to protein kinase A (PKA), cyclic AMP-dependent PKA activity, and protein levels of selective regulatory and catalytic subunit isoforms of PKA in rat brain.  294:103-116. 2000
  • Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C (PKC) and phosphoinositide-specific phospholipase C (PI-PLC) activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain.  291:688-704. 1999
  • Acute regulation of norepinephrine transport: I. Protein kinase C- linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells.  287:733-743. 1998
  • Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro.  279:1462-1469. 1996
  • Use of nitric oxide-nucleophile adducts as biological sources of nitric oxide: Effects on airway smooth muscle.  278:1269-1275. 1996
  • Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation.  276:342-352. 1996
  • Alkylglycosides enhance systemic absorption of insulin applied topically to the rat eye.  271:1274-1280. 1994
  • Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney.  268:1605-1611. 1994
  • Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.  267:657-663. 1993
  • Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.  269:867-880. 1993
  • Effect of the ANF analog A68828 in cisplatin-induced acute renal failure.  257:1179-1183. 1991
  • Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure.  255:1166-1169. 1990
  • Colonic absorption of insulin: An in vitro and in vivo evaluation.  248:567-572. 1989
  • Effects of phenothiazines on the Na+-H+ exchanger of the brush-border membrane from the proximal small intestine of the rabbit.  245:823-828. 1988
  • Thromboxane synthesis and actions in isolated adrenergic nerve (pheochromocytoma-12) cells.  247:43-46. 1988
  • Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: Studies in conscious Brattleboro and Long-Evans rats.  242:143-151. 1987
  • Inhibition of brush-border membrane Na+-H+ exchanger by loperamide.  243:150-154. 1987
  • Inhibition of human placental Na+-H+ exchanger by cimetidine.  239:192-197. 1986
  • Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.  239:426-432. 1986
  • Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.  236:735-742. 1986
  • Increased renal tubular sodium pump and Na+,K+-adenosine triphosphatase in streptozotocin-diabetic rats.  229:664-670. 1984
  • Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.  228:370-375. 1984
  • Properties of a pure metabolically active glomerular preparation from rat kidneys. I. Isolation.  187:332-341. 1973
  • Effects of ethacrynic acid on oxidative metabolism in isolated glomeruli..  187:352-364. 1973
  • Properties of a pure metabolically active glomerular preparation from rat kidneys. II. Metabolism..  187:342-351. 1973